ErbB- and MUC1-targeted CAR-T cell immunotherapy of oral squamous cell carcinoma
Chimeric antigen receptor T (CAR-T) cell therapy has shown great success in treating B cell malignancies; however, there are many challenges that limit their therapeutic efficacy in solid tumours. Immunotherapy of head and neck squamous cell carcinoma (HNSCC), and, in particular, oral squamous cell...
Saved in:
| Main Authors: | Saffron E. Summers, Vehid Salih, Andrew D. Foey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Dental Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdmed.2023.1116402/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitamin D ameliorates prediabetic cardiac injure via modulation of the ErbB4/ferroptosis signaling axis
by: Yufan Miao, et al.
Published: (2025-07-01) -
Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data
by: William W Chen, et al.
Published: (2009-01-01) -
Caracterización de cultivos neuronales de hipocampo murino como modelo de estudio de la señalización NRGs/ErbB4
by: Luis Felipe Monge-Mora, et al.
Published: (2021-12-01) -
Exploring the Effects of Acupuncture on Behaviors of Autism Spectrum Disorder Based on the NRG1/ErbB4 Signaling Pathway
by: ZHUANG Wanyu, et al.
Published: (2025-02-01) -
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma
by: Laura M. Moser, et al.
Published: (2025-02-01)